FDA: Many CBD products contain far less, sometimes more, than advertised
Published in
1 min readJul 10, 2020
David Culver, Canopy Growth’s Vice President of Government and Stakeholder Relations highlights Canopy’s position on the recent testing of CBD-infused products and labeling by the U.S. Food and Drug Administration.
Read the full story here.
